comparemela.com

Latest Breaking News On - Biomedical corporation shifa - Page 1 : comparemela.com

Shifa Launches with Seed Financing to Address Cardiovascular Disease by Developing Orally Bioavailab

- Collaboration with Xontogeny provides funding and key advisory support for early development -MALVERN, Pa. (BUSINESS WIRE) #Cardiovascular Shifa Biomedical Corporation (Shifa), a drug discovery company developing an oral small molecule PCSK9/low density lipoprotein-cholesterol receptor (LDLR) antagonist, P-21,.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.